Clinical studies with spleen-specific radiolabeled agents.

Area of Science:

• Nuclear Medicine
• Diagnostic Imaging
• Radiopharmacology

Background:

• 99mTc sulfur colloid imaging is the primary spleen imaging modality due to accessibility.
• Limitations exist, particularly in visualizing pathology with poor radiocolloid uptake or overlapping organs.

Purpose of the Study:

• To evaluate the utility of selective spleen scanning using damaged 99mTc-labeled red blood cells (RBCs).
• To identify specific clinical indications where this technique provides superior diagnostic information compared to standard imaging.

Main Methods:

• Utilized damaged 99mTc-labeled RBCs for selective spleen scanning.
• Compared findings with standard 99mTc sulfur colloid imaging.

Main Results:

• 99mTc-denatured RBC scans are beneficial for cases with overlapping left hepatic lobes and suspected splenic pathology with poor radiocolloid uptake.
• This method aids in detecting residual splenic tissue post-splenectomy, asplenia, polysplenia, and situs ambiguus.
• It effectively confirms or excludes defects noted on radiocolloid scans and identifies small splenic tissue remnants.

Conclusions:

• Selective spleen scanning with 99mTc-denatured RBCs offers complementary diagnostic value in specific spleen imaging situations.
• It enhances the detection and characterization of splenic abnormalities and congenital anomalies.